Daiichi Sankyo to pay Merck $170 million for cancer test drug rights
Daiichi Sankyo will pay Merck & Co. Inc., $170 million upfront to bag commercialization and development rights of the latter’s test drug for
Drugs
Health
Pharma
Drugs
Health
Pharma
Scientists develop potential compound to neutralise flesh-eating bacteria
A family of antimicrobial compounds can neutralise necrotising fasciitis, a deadly bacterial skin infection that is also known as flesh-eating disease, when tested
Drugs
Health
Pharma
New cardiovascular risk calculator may impose a burden on 16 million US citizens
HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the
Drugs
Health
Pharma
Contineum’s test drug may reverse multiple sclerosis damage
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Drugs
Medical
Pharma
Oxford spin-off develops new test to detect heart attacks 10 yrs in advance
Caristo Diagnostics, founded by four Oxford University cardiologists, has developed an AI-assisted software that can detect cardiac events a decade in advance.
Drugs
Medical
Pharma
Artificial blood vessels can improve heart surgery outcomes: UoE
Flexible, gel-like synthetic tubes can replace human veins during heart bypass operations to reroute blood flow, according to engineers at the University of
Drugs
Health
Pharma
Untreated vision loss, high LDL cholesterol risk factors for dementia
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,
Drugs
Health
Pharma
GenX faces a higher risk of 17 cancer types than older generation
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in
Drugs
Health
Pharma
WHO warns on drug-resistant Klebsiella Pneumonie spread
HQ Team August 4, 2024: The WHO has warned about the rising global incidence of hypervirulent and multi-resistant Klebsiella Pneumoniae (hvKp) infections. The
Drugs
Health
Pharma
US regulator allows GSK’s endometrial cancer therapy for expanded use
The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.